Pharmacy and therapeutic committees view potential cost savings as the most important factor when recommending formulary placement, according to a new survey.
With rising prescription drug prices challenging payers, how are their key decision makers adjusting their approach to recommending coverage for medicines?
A new survey finds that pharmacy and therapeutic committees, whose job it is to assess the clinical effectiveness of new drugs, view potential cost savings as the most important factor when recommending formulary placement. A formulary is a list of drugs that receive preferred coverage.
On a scale of one to six, potential cost savings of a drug ranked highest, at 3.8. This priority edged out the overall safety and efficacy of a drug relative to directly comparable medicines, at 3.7, according to the survey of P&T committees conducted by Barclays Bank analysts.
Read more at The Wall Street Journal: http://on.wsj.com/1H1vYkb
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More